Cabgon 0.5 Tablet

Introduction

Cabgon is a medication that contains the active ingredient Cabergoline. It is available under the brand name Cabgon. This medication is primarily used to treat certain medical conditions related to the overproduction of a hormone called prolactin.

Uses

Cabgon is prescribed for the treatment of hyperprolactinemia, a condition characterized by high levels of prolactin in the blood. It is also used to treat disorders such as prolactinomas and Parkinson’s disease.

Dosage and Administration

The dosage of Cabgon may vary depending on the specific condition being treated and individual patient factors. Follow the instructions provided by your healthcare professional. Generally, the initial recommended dose is usually low, with gradual increases as needed. The tablet is taken orally with or without food.

Mechanism of Action

Cabergoline, the active ingredient in Cabgon, works by reducing the release of prolactin from the pituitary gland in the brain. By doing so, it helps to normalize prolactin levels in the blood. In the treatment of Parkinson’s disease, Cabergoline acts as a dopamine receptor agonist, helping to improve motor symptoms.

Side Effects

Common side effects may include nausea, headache, dizziness, and fatigue. Note that not all patients will experience these side effects, and they may vary in severity. If you experience any persistent or bothersome side effects, it is recommended to consult your healthcare professional.

Serious side effects are rare but may include hallucinations, chest pain, shortness of breath, sudden mood changes, or signs of circulation problems. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

Cabgon may interact with certain medications, including other drugs that affect dopamine levels. Inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. They can help determine if any potential drug interactions may occur.

Precautions

Before taking Cabgon, inform your healthcare professional about any underlying medical conditions or allergies you may have. This medication is not recommended for use during pregnancy or while breastfeeding. Avoid alcohol consumption while taking Cabgon, as it may increase the risk of certain side effects.

Cabgon should be used with caution in patients with a history of heart valve disorders or certain psychiatric conditions. Follow your healthcare professional’s guidance and to report any unusual symptoms or concerns.

Storage

Cabgon should be stored at room temperature, away from moisture and direct sunlight. Keep it out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Cabgon exactly as prescribed by your healthcare professional.
• It may take some time for the medication to show its full effects. Be patient and continue taking it as directed.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular dosing schedule.
• Do not stop taking Cabgon without consulting your healthcare professional, as abrupt discontinuation may lead to a recurrence of symptoms.
• If you have any questions or concerns about Cabgon or its use, consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Cabaser 1 mg Tablets (Health Professionals SmPC) Available at:
• Cabergoline (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
• cabergoline (RX) [Accessed 16 Jun. 2024] (online) Available at:
• Cabergoline (MedlinePlus) [Accessed 18 Jun. 2024] (online) Available at:
• Gadelha MR, Wildemberg LE, Shimon I. Pituitary acting drugs: cabergoline and pasireotide. Pituitary. 2022 Oct;25(5):722-725. doi: 10.1007/s11102-022-01238-8. Epub 2022 Jun 7. [Accessed 15 Jun. 2024] Available at: